039200 - Oscotec, Inc.

039200 Summary
Biopharma
Stock Price & Overview
₩36,600 +700 (+1.95%) Close · Sep 4, 2026 KST
KOSDAQ | ₩KRW | Close: ₩36,600  ≈ US$26  ·  Market cap ₩1.4tn (≈ $1.0bn)

Material matter affecting investment judgment (clinical trial result)

kstock has not written this one up. The title above is a translation of the Korean form name; the filing itself is on DART, in Korean.

Read the original on DART ↗ Korean. DART is Korea's electronic disclosure system, run by the Financial Supervisory Service — the filing equivalent of EDGAR.
Korean form name: 투자판단관련주요경영사항(임상시험결과) (알츠하이머 치료 후보물질 ADELY01 임상 1a/1b상 임상시험결과보고서(CSR) 수령)